Novartis After Sandoz: The Business Without Generics
Novartis is thriving with double-digit growth, driven by key drugs in oncology, cardiology, immunology, and neurology. See ...
ROSEN, A LEADING NATIONAL FIRM, Encourages Viatris Inc. Investors to Inquire About Securities Class Action Investigation - VTRS
New York, New York-- (Newsfile Corp. - April 6, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of ...
The News Herald16h
How Trump's latest tariffs could affect your wallet
The sweeping new tariffs, coming on top of previous levies and retaliation worldwide, are expected to increase prices for ...